摘要 |
The present invention provides, at least in part, compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein Z<SUB>1,</SUB> Z<SUB>2</SUB>, Z<SUB>3</SUB>, R<SUB>1</SUB>, x, y, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4a</SUB>, R<SUB>4b</SUB>, R<SUB>5</SUB>, R<SUB>6</SUB> and R<SUB>7</SUB> are described herein, as well as methods for their identification, their preparation, pharmaceutical compositions containing them, and their use as Aurora A kinase inhibitors in treatment, e.g., of cancer and other proliferative disorders. |